drugset / Trial / NCT05922696

Cholecalciferol Supplementation in Hemodialysis Patients

NCT05922696

Phase 2/3 Completed 50 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

This is prospective single-blind randomized study, in Ain Shams University hospital) in Egypt, to assess the impact of Cholecalciferol on Anemia status in regular hemodialysis outpatients

Timeline

Start
2022-05-15
Primary completion
2022-09-15
Completion
2023-01-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu Oral
Comparator Cholecalciferol Other / unclassified 200000 iu Oral